Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care
This appointment situates Massive Bio at the forefront of a national public-private partnership aiming to revolutionize the fight against cancer.
- This appointment situates Massive Bio at the forefront of a national public-private partnership aiming to revolutionize the fight against cancer.
- View the full release here: https://www.businesswire.com/news/home/20230604005029/en/
FINAL CancerX Founding Members Logo Cloud (Graphic: Business Wire)
As cancer continues to pose a significant global challenge, Massive Bio stands committed to mitigating this scourge. - Being chosen as a founding member of CancerX confirms our dedication to advancing precision oncology and democratizing access to groundbreaking cancer treatments.
- CancerX is primarily focused on advancing digital innovation to improve equity and reduce financial toxicity in cancer care and research.